Auditor Mazars USA LLP resigns; company seeks replacement

Accustem Sciences Inc.

Mazars to resign effective with Q1 2024 10-Q filing, no later than May 31, 2024.
No adverse opinions or disagreements for fiscal years 2022 and 2023.
Company disclosed material weakness in internal control over financial reporting due to lack of accounting resources.
Company is in process of retaining a new independent registered public accounting firm.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.